The global PD-1 and PD-L1 inhibitor market is estimated to be valued at US$30,535.5 Mn in 2021 and is expected to exhibit a CAGR of 14.2% over the forecast period of 2022-2030, as highlighted in a new report published by Coherent Market Insights.A) Market Overview:PD-1 and PD-L1 inhibitors are a new class of drugs that have revolutionized cancer treatment. These inhibitors work by blocking the...